S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

Plain-language summary

This study analyzes protein expression (protein levels) in the laboratory in breast cancer tissue samples from a prior clinical trial (SWOG-9313). It included patients with Stage I-IIIA breast cancer whose tissue was banked. It is a non-phase laboratory analysis study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

SWOG Cancer Research Network

Intervention

gene expression analysis, protein expression analysis, fluorescent antibody technique, laboratory biomarker analysis

Start date

7/17/2006

Estimated completion

4/2/2009

Countries

United States

Related genes

Locations

• New Haven, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

DISEASE CHARACTERISTICS:

* Diagnosis of primary invasive adenocarcinoma of the breast

  * Stage I-IIIA disease (T1-3, N0-1, M0)
* Enrolled on clinical trial SWOG-9313
* Tumor tissue available for testing

PATIENT CHARACTERISTICS:

* Not specified

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics